LILRB4 and autoimmune disease: The results show that LILRB4 and its derived recombinant protein LILRB4-Fc have strong immunosuppressive effects and play a key role in the treatment of autoimmune diseases, the induction of transplantation tolerance and the induction of maternal–fetal immune tolerance.